Stock Markets

Daily coverage of equity markets, sectors, and major indices.

In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.

Articles

25,383 total articles

Playtech Shares Jump Nearly 19% on Company-Specific Catalyst

Playtech Shares Jump Nearly 19% on Company-Specific Catalyst

Playtech's stock jumped 18.8% to 380.4p on heavy intraday gains, driven by a company-specific development in the absence of any confirmed July 9, 2026 press release. The surge builds on management commentary of robust early-2026 trading and marks a notable move toward sell-side price targets from Deutsche Bank and Citi.

S-Bank's €17.20 cash offer sparks 44% rally in Oma Savings Bank shares

S-Bank's €17.20 cash offer sparks 44% rally in Oma Savings Bank shares

Shares of Oma Savings Bank Plc jumped 43.9% to €16.84 after S-Bank Plc announced a voluntary recommended public cash tender offer of €17.20 per share for all outstanding shares. The €17.20 price implies a roughly 52.5% premium to the 12-month volume-weighted average trading price and about a 47.0% premium to the closing price on 8 July 2026. Key in…

AI Pivot Powers Big Gains: Penguin Solutions Jumps 25% After Record Quarter; AI Picks Continue to Outperform

AI Pivot Powers Big Gains: Penguin Solutions Jumps 25% After Record Quarter; AI Picks Continue to Outperform

Summary - Subscribers to the platform's AI-driven pick service have continued to capture outsized returns, with a new standout in July: Penguin Solutions. After reporting record quarterly net sales and a better-than-expected EPS, Penguin surged roughly 25% in a single session. The move follows earlier June winners and a roster of July performers, w…

Asian Investors Seek AI Winners That Can Also Withstand Disruption

Asian Investors Seek AI Winners That Can Also Withstand Disruption

At a finance summit in Singapore, large fund managers described a cautious approach to artificial intelligence, balancing investments in AI-related opportunities with allocations to businesses perceived as less vulnerable to AI disruption. While global markets have rallied on AI excitement, speakers warned about stretched valuations, uncertain retu…

European equities edge higher as tech rebounds; Middle East tensions and trial setback weigh

European equities edge higher as tech rebounds; Middle East tensions and trial setback weigh

European stocks ticked up amid a technology-led rebound, tempered by market attention on Middle East developments and a significant clinical trial disappointment at a major drugmaker. The STOXX 600 rose modestly, chipmakers outperformed and crude oil eased slightly as investors reacted to comments about Iran and subsequent U.S. strikes. Separately,…

Jefferies Keeps Alibaba at Top of China Internet Picks, Citing AI Momentum and Stable Core Business

Jefferies Keeps Alibaba at Top of China Internet Picks, Citing AI Momentum and Stable Core Business

Jefferies reiterated Alibaba as its preferred holding within the China Internet sector, highlighting the company’s execution capabilities and accelerating demand for artificial intelligence services. The broker expects the June quarter to show steady performance, driven by a resilient e-commerce base and rapid growth at Alibaba’s Cloud Intelligent …

Tokyo Stocks Close Higher Driven by Real Estate, Banking and Tech Gains

Tokyo Stocks Close Higher Driven by Real Estate, Banking and Tech Gains

The Nikkei 225 rose 1.55% at Thursday's Tokyo close, supported by strength in Real Estate, Banking and Textile sectors. Semiconductor-related names and electronics equipment makers were among the session's top performers, while materials and industrials faced notable declines. Market breadth was mixed and implied volatility in Nikkei options jumped…

Mizuho Highlights U.S. Healthcare Names with Near-Term Catalysts and Commercial Upside

Mizuho Highlights U.S. Healthcare Names with Near-Term Catalysts and Commercial Upside

Mizuho has singled out seven U.S. healthcare companies it views as set up for potential upside based on upcoming clinical readouts, commercial rollouts and efficiency actions. The list spans ophthalmology, vaccines, oncology, dermatology, diagnostic imaging, inpatient rehabilitation and med-surgical supplies, with firm-specific timelines and revenu…

4C Group Posts 26% Q2 Revenue Gain as Defence Software Sales Accelerate

4C Group Posts 26% Q2 Revenue Gain as Defence Software Sales Accelerate

4C Group AB reported second-quarter net sales of SEK 95.40 million, a 26% rise year-over-year and ahead of the single analyst estimate of SEK 74 million. The firm returned to positive EBIT of SEK 13.20 million with a 14% margin and posted net income of SEK 15.10 million, while software sales grew 52% and comprised 67% of total revenue. A SEK 700 mi…

Capita posts modest revenue rise but flags pension-related costs for 2026

Capita posts modest revenue rise but flags pension-related costs for 2026

Capita plc reported adjusted revenue growth of 1.6% in the first half of 2026 and secured £1 billion of new contracts, marking its strongest Public Services first-half showing since 2021. The company extended its revolving credit facility to £325 million to June 2029, but warned that problems on the Civil Service Pension Scheme contract will reduce…

Fast Retailing Posts 45.7% Quarterly Profit Gain, Lifts Full-Year Outlook

Fast Retailing Posts 45.7% Quarterly Profit Gain, Lifts Full-Year Outlook

Fast Retailing, the operator of Uniqlo, reported a 45.7% rise in operating profit for the quarter through May and has raised its full-year operating profit forecast. The company cited persistent supply-chain challenges linked to the Iran war and noted divergent demand trends across regions, including slowed growth in China and tourism-driven streng…

Schott Pharma Raises Full-Year Targets After Settling Glass Syringe Dispute

Schott Pharma Raises Full-Year Targets After Settling Glass Syringe Dispute

Schott Pharma AG & Co. KGaA raised its 2026 revenue growth and EBITDA margin guidance after reporting stronger-than-expected preliminary third-quarter figures and reaching a settlement with a major glass syringe customer whose earlier breakdown had led to a profit warning in December 2025. The company cited solid business performance, expectations …